{"unnormalised": "AIIMS Delhi has announced a breakthrough in treating early-stage oral cancer. A clinical trial using a novel combination of chemotherapy and radiation therapy has shown promising results, with a 90% remission rate observed in patients treated at the institute. The study, led by Dr. Rajesh Kumar, head of Oncology, involved 150 patients diagnosed with Stage I or Stage II oral squamous cell carcinoma.", "normalised": "A-I-I-M-S Delhi has announced a breakthrough in treating early-stage oral cancer. A clinical trial using a novel combination of chemotherapy and radiation therapy has shown promising results, with a ninety percent remission rate observed in patients treated at the institute. The study, led by Doctor Rajesh Kumar, head of Oncology, involved one hundred and fifty patients diagnosed with Stage one or Stage two oral squamous cell carcinoma."}
{"unnormalised": "The treatment protocol consisted of Cisplatin at 100mg/m2 administered every 3 weeks along with conventional radiotherapy at a dose of 66 Gy delivered over 6-7 weeks. Researchers noted a significant reduction in tumor size within 4 weeks of initiating treatment. Detailed findings from the study were presented at the International Conference on Cancer Research held on 22/07/2024, highlighting the potential for this approach to become a standard treatment for early-stage oral cancer in India.", "normalised": "The treatment protocol consisted of Cisplatin at one hundred milligram per meter squared administered every three weeks along with conventional radiotherapy at a dose of sixty six Gray delivered over six to seven weeks. Researchers noted a significant reduction in tumor size within four weeks of initiating treatment. Detailed findings from the study were presented at the International Conference on Cancer Research held on twenty second July two thousand and twenty four, highlighting the potential for this approach to become a standard treatment for early-stage oral cancer in India."}
{"unnormalised": "Further research is underway to assess the long-term efficacy and toxicity of the treatment regimen. AIIMS plans to conduct larger multi-center trials to validate these findings across diverse patient populations. The cost of the treatment is estimated at Rs. 1,50,000, making it a relatively affordable option compared to other advanced cancer therapies.", "normalised": "Further research is underway to assess the long-term efficacy and toxicity of the treatment regimen. A-I-I-M-S plans to conduct larger multi-center trials to validate these findings across diverse patient populations. The cost of the treatment is estimated at rupees one lakh fifty thousand, making it a relatively affordable option compared to other advanced cancer therapies."}
